Literature DB >> 29991543

Empirical treatment of tuberculosis: TB or not TB?

Eika Webb1, Narmadha Kali Vanan1, Rakesh Biswas2.   

Abstract

Of the 8.6 million new cases of tuberculosis (TB) that occur globally each year, a quarter occur in India. We describe the case of a 38-year-old Indian woman who presented with symptoms of hepatitis after being treated empirically with anti-TB therapy for five months. The patient was suspected to have TB after having recurrent episodes of coughing which would improve briefly before her respiratory symptoms returned, which led to her being treated at various healthcare clinics and hospitals. We highlight the challenges the patient faced due to the lack of centralised medical records which would have prevented unnecessary investigations and treatment. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs and medicines; gastrointestinal system; global health; healthcare improvement and patient safety

Mesh:

Substances:

Year:  2018        PMID: 29991543      PMCID: PMC6047727          DOI: 10.1136/bcr-2018-224166

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.

Authors:  Vidyasagar Ramappa; Guruprasad P Aithal
Journal:  J Clin Exp Hepatol       Date:  2012-12-20

2.  Should sputum-negative presumptive TB patients be actively followed to identify missing cases in India?

Authors:  S Waikar; A Pathak; V Ghule; A Kapoor; K Sagili; E R Babu; S Chadha
Journal:  Public Health Action       Date:  2017-12-21

3.  An exploration of the value of the personal doctor-patient relationship in general practice.

Authors:  K E Kearley; G K Freeman; A Heath
Journal:  Br J Gen Pract       Date:  2001-09       Impact factor: 5.386

Review 4.  Does continuity of care improve patient outcomes?

Authors:  Michael D Cabana; Sandra H Jee
Journal:  J Fam Pract       Date:  2004-12       Impact factor: 0.493

5.  Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

Authors:  Grant Theron; Jonny Peter; David Dowdy; Ivor Langley; S Bertel Squire; Keertan Dheda
Journal:  Lancet Infect Dis       Date:  2014-01-15       Impact factor: 25.071

6.  Interaction between diabetic patients, their general practitioners and a hospital diabetic clinic.

Authors:  M Constantino; P L Hoskins; P M Fowler; C Pech; R McFarlane; J R Flack; J Forrest; D K Yue; J R Turtle
Journal:  Med J Aust       Date:  1991-10-21       Impact factor: 7.738

Review 7.  Primary care. Participants or gatekeepers?

Authors:  B Starfield
Journal:  Diabetes Care       Date:  1994-06       Impact factor: 19.112

8.  From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts.

Authors:  Srinath Satyanarayana; Sreenivas Achutan Nair; Sarabjit Singh Chadha; Roopa Shivashankar; Geetanjali Sharma; Subhash Yadav; Subrat Mohanty; Vishnuvardhan Kamineni; Nevin Charles Wilson; Anthony David Harries; Puneet Kumar Dewan
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

9.  Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010.

Authors:  Kuldeep Singh Sachdeva; Srinath Satyanarayana; Puneet Kumar Dewan; Sreenivas Achuthan Nair; Raveendra Reddy; Debasish Kundu; Sarabjit Singh Chadha; Ajay Kumar Madhugiri Venkatachalaiah; Malik Parmar; Lakhbir Singh Chauhan
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

10.  Improving the estimation of the tuberculosis burden in India.

Authors:  Krycia Cowling; Rakhi Dandona; Lalit Dandona
Journal:  Bull World Health Organ       Date:  2014-08-20       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.